These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. H2-receptor antagonists in the treatment of peptic ulcer. Isenberg JI Ann Intern Med; 1976 Feb; 84(2):212-4. PubMed ID: 3128 [No Abstract] [Full Text] [Related]
6. Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Pinder RM; Brogden RN; Sawyer PR; Speight TM; Spencer R; Avery GS Drugs; 1976; 11(4):245-307. PubMed ID: 780088 [TBL] [Abstract][Full Text] [Related]
7. [Peptic ulcer: new aspects of conservative therapy]. Bernoulli R Schweiz Med Wochenschr; 1977 May; 107(18):618-22. PubMed ID: 17157 [TBL] [Abstract][Full Text] [Related]
8. Drugs for peptic ulcer. Invited commentary. Grossman MI World J Surg; 1977 Jan; 1(1):7-8. PubMed ID: 17231 [No Abstract] [Full Text] [Related]
9. Histamine H2-receptor antagonists in the treatment of duodenal ulcers. Bank S; Barbezat GO; Novis BH; Tim LO; Odes HS; Helman C; Narunsky L; Duys PJ; Marks IN S Afr Med J; 1976 Oct; 50(44):1781-5. PubMed ID: 11564 [TBL] [Abstract][Full Text] [Related]
10. [Role of surgery in the therapy of peptic ulcer after arrival of H2-blocking drugs]. Perri S; Amendolara M; Breda E; Todarello V; Gallo G; Pietrangeli F; Meneghini G; Gelmi GF G Chir; 1990 Sep; 11(9):466-70. PubMed ID: 1981139 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of ulcers with pirenzepin. Results from clinic and practice]. Krempler F; Sandhofer F; Kalk A Wien Med Wochenschr; 1982 Sep; 132(18):427-32. PubMed ID: 6760563 [TBL] [Abstract][Full Text] [Related]
13. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers. Deakin M; Williams JG Drugs; 1992 Nov; 44(5):709-19. PubMed ID: 1280563 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of peptic ulcer in the stomach and duodenum using carbenoxolone (Biogastrone and Biogastrone-Duodenal)]. Ronský R; Fric P; Huslarová A; Malis F; Josífko M Cesk Gastroenterol Vyz; 1978 Mar; 32(2):98-104. PubMed ID: 350435 [No Abstract] [Full Text] [Related]
15. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists]. Hentschel E Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397 [No Abstract] [Full Text] [Related]
16. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"]. Gorshkov VA Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232 [No Abstract] [Full Text] [Related]
17. [Currents aspects of H2 receptor antagonists in the treatment of ulcers]. Debongnie JC Acta Gastroenterol Belg; 1992; 55(5-6):415-22. PubMed ID: 1363166 [TBL] [Abstract][Full Text] [Related]
18. Comments on the effects of carbenozolone and trimipramine on peptic ulcer healing. Myren J; Berstad A Scand J Gastroenterol Suppl; 1976; 42():159-61. PubMed ID: 796969 [No Abstract] [Full Text] [Related]
19. Carbenoxolone sodium in the treatment of peptic ulcer. A review. Lewis JR JAMA; 1974 Jul; 229(4):460-2. PubMed ID: 4600402 [No Abstract] [Full Text] [Related]